Company intelligence / Profile preview

Kirkbride Center

Philadelphia, Pennsylvania, United States

Ownership: Private
Employees: ~309
Development stage: Other

Overview

Kirkbride Center is a comprehensive behavioral health care facility offering 302 beds for addiction treatment, including detoxification, residential rehabilitation, and medication-assisted therapies such as methadone, Suboxone, and Vivitrol. It holds Joint Commission accreditation and serves both the local Philadelphia community and referred patients. No pharmaceutical clinical trials or pipelines are reported.

Therapeutic areas: Psychiatry
Modalities: Medication-Assisted TreatmentDetoxificationResidential Rehabilitation
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Kirkbride Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kirkbride Center.

Explore the full profile